NEW YORK (GenomeWeb) – Exact Sciences today announced that Aetna will cover its Cologuard test under its Medicare Advantage plan, which serves 967,000 members across the country.

The three-year contract goes into effect on April 1, 2015, the Madison, Wis.-based molecular diagnostics firm said. Cologuard will be available to Aetna's Medicare Advantage members through their physician without a co-payment or co-insurance, Exact Sciences noted.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.